Health
Ex-Pfizer Employee Convicted of Insider Trading on Covid Pill
- Amit Dagar and friend made more than $270,000, prosecutors say
- Verdict is another victory in US crackdown on insider trading
Prosecutors said Dagar was a senior statistical program lead for the randomized, double-blind Paxlovid trial, which began in July 2021.
Photographer: Kobi Wolf/BloombergThis article is for subscribers only.
A former Pfizer Inc. employee was convicted of using confidential information about the company’s Covid-19 treatment to make illegal options trades, giving federal prosecutors yet another victory in their attempts to clamp down on insider trading.
Amit Dagar was found guilty on securities fraud and conspiracy following a one-week trial in federal court in New York before US District Judge Andrew Carter. He faces as much as 20 years in prison on the securities fraud charge at sentencing.